02203nas a2200217 4500008004100000245005600041210005500097260001700152300000800169490000600177520159200183653002401775653002701799653001701826100001701843700001701860700002501877700002001902700001601922856004701938 2022 eng d00aAntibiotic Resistance: A Universal Issue of Concern0 aAntibiotic Resistance A Universal Issue of Concern cJanuary 2022 a4-70 v83 a
The antibiotic resistance forthwith is the worldwide severe health problem. Clinical and economically, outcomes are harmed by the antibiotic resistance, along with consequences ranging from a patient’s failure to respond treatment and the expensive and alternative drugs costs higher morbidity and mortality rates, preponderant hospital stays and the need for changes in standard therapy. The usage of antibiotic in the population as a whole a few leading sources of antibiotic resistance. Patients who do not have a prescription are frequently given ‘prescription-only’ medications like antibiotics by pharmacists in undeveloped nations like India. There is a lack of information on how community pharmacists use antibiotics which is critical for developing a viable and long-term intervention programmed to encourage judicious antibiotic use. Antibiotics are one of the most effective weapons to fight against life-threatening illnesses. Their discoveries have a significant impact on human as well as animal health. Consequently, because of the advent and spread of antimicrobial resistance, people all around the world including Americans are sinking due to intractable diseases. In this review, we will look at the trapping of antibiotic resistance on the general public health, community, society and health care system. Resistance to antibiotics is a danger sign that is putting strain on healthcare systems and resulting in severe health loss; we must continue to monitor and support activities aimed at preventing and controlling the infection.
10aClinical Pharmacist10aInfection Control Team10aPrescribers.1 aKhan, Hashim1 aMalik, Abdul1 aGaur, Praveen, Kumar1 aRastogi, Sameer1 aLata, Kanak uhttps://www.jppcm.org/article/2022/8/1/4-701699nas a2200229 4500008004100000245010900041210006900150260001800219300001000237490000600247520101500253653000901268653002001277653001001297653001801307653002301325653001701348100002101365700001701386700001701403856004901420 2021 eng d00aBCG Induced Lymphadenitis: A Prerequisite in Parental Counseling during Pre and Post Vaccination Program0 aBCG Induced Lymphadenitis A Prerequisite in Parental Counseling cDecember 2021 a49-500 v73 aBacillus-Calmette-Guerin (BCG) is a live attenuated vaccine and used to prevent tuberculosis since 1921. BCG vaccination is performed as a part of expanded program of immunization (EPI). BCG vaccine is considered as a safe technique of tuberculosis prevention because there are only local adverse reactions seen with this and serious adverse reactions are rare. Lymphadenitis is the most frequent side effect of BCG vaccination. Intradermal BCG vaccination gives rise to erythromatous formation that consists of a cutaneous nodule at the site of injection and subclinical involvement of the regional lymph nodes, which is self limiting and requires no treatment. Lymphadenitis is the most frequent side effect of BCG vaccination. Fine needle aspiration is the quick, safe, and cost effective technique for diagnosis in addition to the management of BCG lymphadenitis. Here we report a case of 10- months’ healthy male patient with left axillary lymphadenitis post BCG vaccination.
10aAEFI10aBCG vaccination10aFNAC.10aLymphadenitis10aPatient counseling10atuberculosis1 aSharma, Abhishek1 aBano, Gulnaz1 aMalik, Abdul uhttps://www.jppcm.org/article/2021/7/3/49-50